These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 9925657)
1. Presecretory degradation of apolipoprotein [a] is mediated by the proteasome pathway. White AL; Guerra B; Wang J; Lanford RE J Lipid Res; 1999 Feb; 40(2):275-86. PubMed ID: 9925657 [TBL] [Abstract][Full Text] [Related]
2. Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance. Bush KT; Goldberg AL; Nigam SK J Biol Chem; 1997 Apr; 272(14):9086-92. PubMed ID: 9083035 [TBL] [Abstract][Full Text] [Related]
3. The proteasome participates in degradation of mutant alpha 1-antitrypsin Z in the endoplasmic reticulum of hepatoma-derived hepatocytes. Teckman JH; Burrows J; Hidvegi T; Schmidt B; Hale PD; Perlmutter DH J Biol Chem; 2001 Nov; 276(48):44865-72. PubMed ID: 11577074 [TBL] [Abstract][Full Text] [Related]
4. Role of calnexin, calreticulin, and endoplasmic reticulum mannosidase I in apolipoprotein(a) intracellular targeting. Wang J; White AL Biochemistry; 2000 Aug; 39(30):8993-9000. PubMed ID: 10913312 [TBL] [Abstract][Full Text] [Related]
5. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. Schubert U; Antón LC; Bacík I; Cox JH; Bour S; Bennink JR; Orlowski M; Strebel K; Yewdell JW J Virol; 1998 Mar; 72(3):2280-8. PubMed ID: 9499087 [TBL] [Abstract][Full Text] [Related]
6. Degradation of a mutant secretory protein, alpha1-antitrypsin Z, in the endoplasmic reticulum requires proteasome activity. Qu D; Teckman JH; Omura S; Perlmutter DH J Biol Chem; 1996 Sep; 271(37):22791-5. PubMed ID: 8798455 [TBL] [Abstract][Full Text] [Related]
7. Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full-length apolipoprotein B after translocation into the endoplasmic reticulum. Liao W; Yeung SC; Chan L J Biol Chem; 1998 Oct; 273(42):27225-30. PubMed ID: 9765244 [TBL] [Abstract][Full Text] [Related]
8. Effects of tocotrienol on the intracellular translocation and degradation of apolipoprotein B: possible involvement of a proteasome independent pathway. Wang Q; Theriault A; Gapor A; Adeli K Biochem Biophys Res Commun; 1998 May; 246(3):640-3. PubMed ID: 9618265 [TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-proteasome pathway mediates intracellular degradation of apolipoprotein B. Yeung SJ; Chen SH; Chan L Biochemistry; 1996 Oct; 35(43):13843-8. PubMed ID: 8901527 [TBL] [Abstract][Full Text] [Related]
10. Synphilin-1 degradation by the ubiquitin-proteasome pathway and effects on cell survival. Lee G; Junn E; Tanaka M; Kim YM; Mouradian MM J Neurochem; 2002 Oct; 83(2):346-52. PubMed ID: 12423244 [TBL] [Abstract][Full Text] [Related]
11. Chaperone interactions of the metalloproteinase meprin A in the secretory or proteasomal-degradative pathway. Tsukuba T; Kadowaki T; Hengst JA; Bond JS Arch Biochem Biophys; 2002 Jan; 397(2):191-8. PubMed ID: 11795871 [TBL] [Abstract][Full Text] [Related]
12. Intracellular maturation of apolipoprotein[a] and assembly of lipoprotein[a] in primary baboon hepatocytes. White AL; Rainwater DL; Lanford RE J Lipid Res; 1993 Mar; 34(3):509-17. PubMed ID: 8468534 [TBL] [Abstract][Full Text] [Related]
13. Ubiquitin-dependent and -independent proteasomal degradation of apoB associated with endoplasmic reticulum and Golgi apparatus, respectively, in HepG2 cells. Liao W; Chang BH; Mancini M; Chan L J Cell Biochem; 2003 Aug; 89(5):1019-29. PubMed ID: 12874835 [TBL] [Abstract][Full Text] [Related]
14. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules. Bai A; Forman J J Immunol; 1997 Sep; 159(5):2139-46. PubMed ID: 9278300 [TBL] [Abstract][Full Text] [Related]
15. Intracellular degradation of secretion defect-type mutants of antithrombin is inhibited by proteasomal inhibitors. Tokunaga F; Shirotani H; Hara K; Kozuki D; Omura S; Koide T FEBS Lett; 1997 Jul; 412(1):65-9. PubMed ID: 9257691 [TBL] [Abstract][Full Text] [Related]
16. Degradation of trafficking-defective long QT syndrome type II mutant channels by the ubiquitin-proteasome pathway. Gong Q; Keeney DR; Molinari M; Zhou Z J Biol Chem; 2005 May; 280(19):19419-25. PubMed ID: 15760896 [TBL] [Abstract][Full Text] [Related]
17. Ubiquitination is required for the retro-translocation of a short-lived luminal endoplasmic reticulum glycoprotein to the cytosol for degradation by the proteasome. de Virgilio M; Weninger H; Ivessa NE J Biol Chem; 1998 Apr; 273(16):9734-43. PubMed ID: 9545309 [TBL] [Abstract][Full Text] [Related]
18. Liver alcohol dehydrogenase is degraded by the ubiquitin-proteasome pathway. Mezey E; Rennie-Tankersley L; Potter JJ Biochem Biophys Res Commun; 2001 Jul; 285(3):644-8. PubMed ID: 11453641 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of N-linked glycosylation results in retention of intracellular apo[a] in hepatoma cells, although nonglycosylated and immature forms of apolipoprotein[a] are competent to associate with apolipoprotein B-100 in vitro. Bonen DK; Nassir F; Hausman AM; Davidson NO J Lipid Res; 1998 Aug; 39(8):1629-40. PubMed ID: 9717723 [TBL] [Abstract][Full Text] [Related]
20. 6-Aminohexanoic acid as a chemical chaperone for apolipoprotein(a). Wang J; White AL J Biol Chem; 1999 Apr; 274(18):12883-9. PubMed ID: 10212277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]